Home » MEDINOL IN NEW PATENT CLAIM VS BOSTON SCIENTIFIC
MEDINOL IN NEW PATENT CLAIM VS BOSTON SCIENTIFIC
Israel's Medinol has lodged a new legal claim against Boston Scientific Corp, asserting several of its patents were violated by the latter's next-generation coronary stents, the Wall Street Journal reported on Wednesday.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
20Jun
-
21Oct